We are live on ! Find out more
AVA

Atlas Venture Advisors Portfolio holdings

AUM $122M
1-Year Est. Return 26.28%
This Fund
S&P 500
This Quarter Est. Return
-4.37%
1 Year Est. Return
-26.28%
3 Year Est. Return
-22.79%
5 Year Est. Return
-46.44%
10 Year Est. Return
–
AUM
$446M
AUM Growth
-$149M
Cap. Flow
-$84.1M
Cap. Flow %
-18.86%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
+$3.76M

Top Sells

Rank Stock Value
1
DKNG icon
DraftKings
DKNG
+$47.6M
2
TBIO
Translate Bio, Inc. Common Stock
TBIO
+$21.1M
3
BCYC
Bicycle Therapeutics
BCYC
+$13.4M
4
DDOG icon
Datadog
DDOG
+$5.78M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 76.05%
2 Healthcare 16.89%
3 Communication Services 7.05%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DKNG icon
1
DraftKings
DKNG
$11.4B
$339M 76.05%
7,284,008
-1,000,000
-12% -$47.6M
TBIO
2
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$49M 10.98%
2,656,517
-1,176,603
-31% -$21.1M
ROKU icon
3
Roku
ROKU
$21.1B
$19.2M 4.3%
57,707
– –
SNAP icon
4
Snap
SNAP
$7.32B
$12.3M 2.76%
245,559
– –
BCYC
5
Bicycle Therapeutics
BCYC
$270M
$11M 2.47%
612,696
-694,269
-53% -$13.4M
LRMR icon
6
Larimar Therapeutics
LRMR
$416M
$6.26M 1.4%
292,184
– –
FSTX
7
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$5.67M 1.27%
+574,996
New +$3.76M
VRDN icon
8
Viridian Therapeutics
VRDN
$2.13B
$3.45M 0.77%
209,505
– –
DDOG icon
9
Datadog
DDOG
$87.9B
– –
-56,616
Closed -$5.78M

Similar funds

RCWM
Red Crane Wealth Management San Francisco, California $122M AUM 14.77% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
SO
Sierra Ocean Ripon, California $122M AUM 16.19% 1-Year Est. Return
MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
VAM
Valliance Asset Management Central, Hong Kong $122M AUM 362.1% 1-Year Est. Return
TCM
TT Capital Management Coto De Caza, California $121M AUM 1.94% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Atlas Venture Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Atlas Venture Advisors held 9 positions worth $446M, down 25% from $594M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Atlas Venture Advisors withdrew a net $84.1M in Q4 2020, closing 1 position and reducing 3 holdings. Its most notable exit was Datadog, an estimated $5.78M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 76% of assets, down from 82% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Atlas Venture Advisors opened a new position in F-star Therapeutics, Inc. Common Stock worth $5.67M.

  • Atlas Venture Advisors's largest Q4 2020 buy was F-star Therapeutics, Inc. Common Stock: 574,996 shares worth $5.67M.
  • Atlas Venture Advisors's biggest Q4 2020 reduction was DraftKings, cutting an estimated $47.6M.
  • Atlas Venture Advisors fully exited Datadog in Q4 2020, selling an estimated $5.78M.
  • Atlas Venture Advisors's ten largest holdings make up 100% of its $446M portfolio in Q4 2020.
  • Atlas Venture Advisors opened 1 new position and closed 1 in Q4 2020.
  • Atlas Venture Advisors's portfolio value fell 25% quarter-over-quarter to $446M.

Based on Atlas Venture Advisors's 13F filing for Q4 2020, filed 1 Feb 2021.